IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.719
EU - Europa 5.260
AS - Asia 4.959
SA - Sud America 720
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 18.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.561
SG - Singapore 2.044
CN - Cina 1.502
IE - Irlanda 949
IT - Italia 840
UA - Ucraina 781
SE - Svezia 691
TR - Turchia 689
BR - Brasile 602
GB - Regno Unito 542
DE - Germania 404
FR - Francia 391
FI - Finlandia 249
IN - India 235
VN - Vietnam 218
RU - Federazione Russa 173
CA - Canada 91
PL - Polonia 62
HK - Hong Kong 59
AR - Argentina 58
MX - Messico 49
JP - Giappone 37
NL - Olanda 36
AT - Austria 35
ZA - Sudafrica 31
BD - Bangladesh 25
ES - Italia 25
KR - Corea 24
ID - Indonesia 21
IQ - Iraq 21
CZ - Repubblica Ceca 18
BE - Belgio 16
EC - Ecuador 16
EU - Europa 11
IR - Iran 10
PK - Pakistan 10
AL - Albania 9
AZ - Azerbaigian 9
CL - Cile 9
LT - Lituania 9
MA - Marocco 9
VE - Venezuela 9
CO - Colombia 8
IL - Israele 8
RO - Romania 8
UZ - Uzbekistan 8
OM - Oman 6
PE - Perù 6
PY - Paraguay 5
QA - Qatar 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KE - Kenya 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BZ - Belize 3
CH - Svizzera 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
LK - Sri Lanka 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.736
Salva come PNG Salva come JPEG
Città #
Singapore 1.536
Chandler 1.086
Jacksonville 959
Dublin 935
Ashburn 616
Dallas 517
Beijing 428
Princeton 383
Southend 370
Izmir 335
Nanjing 235
Los Angeles 227
Dearborn 205
Santa Clara 203
The Dalles 192
Wilmington 185
Cambridge 159
New York 158
Ann Arbor 144
Altamura 134
Chieti 107
Munich 105
Nanchang 99
Tongling 99
Boardman 88
Buffalo 85
Ho Chi Minh City 78
Pescara 75
São Paulo 68
Washington 64
Helsinki 59
Redondo Beach 57
Hong Kong 56
Shenyang 49
Hebei 48
Kunming 47
Brooklyn 46
Woodbridge 44
Hanoi 43
Montreal 42
Tianjin 42
Rome 35
Tokyo 35
Warsaw 35
Turku 34
Changsha 31
Jiaxing 31
Grevenbroich 30
Orem 30
Seattle 30
Hefei 29
Norwalk 29
Augusta 27
Moscow 27
Chicago 26
London 26
Milan 26
Denver 25
Stockholm 25
Poplar 24
Toronto 24
Johannesburg 23
Seoul 23
Nuremberg 22
Chennai 21
Frankfurt am Main 21
Ankara 18
Dong Ket 18
Houston 18
Jinan 18
Atlanta 17
Boston 17
Changchun 17
Lanzhou 17
Mexico City 17
San Mateo 17
Brussels 16
Hangzhou 16
Falls Church 15
Phoenix 15
San Francisco 15
Vienna 15
Amsterdam 14
Brno 14
Rio de Janeiro 14
Belo Horizonte 13
Council Bluffs 13
Manchester 13
Mumbai 13
Shanghai 13
Brasília 12
Guangzhou 11
Lappeenranta 11
Querétaro 11
Charlotte 10
Curitiba 10
Leawood 10
Pune 10
Osasco 9
Paris 9
Totale 11.573
Salva come PNG Salva come JPEG
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 157
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 157
Pentraxin 3 and platelet activation in obese patients after gastric banding 155
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 150
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 143
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 140
Role of growth factors in the development of diabetic complications 140
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 138
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 137
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 136
Determinants of platelet activation in hypertensives with microalbuminuria. 135
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 135
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 134
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 133
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 129
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 129
Platelets and Diabetes 126
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 126
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 125
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 125
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 125
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 125
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 124
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 124
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 122
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 120
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 120
Neurocognitive impairment and suicide risk among prison inmates 120
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 120
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 119
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 119
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 118
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 117
Platelets and diabetes mellitus 117
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 117
The role of antileukotrienes in the treatment of asthma. 116
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 116
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 115
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 115
Coagulation and infective endocarditis: sooner or later 115
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 114
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 113
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 112
Insulin resistance as a determinant of platelet activation in obese women. 112
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 112
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 112
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 110
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 110
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 110
Platelet activation in obesity and metabolic syndrome. 109
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 109
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 108
Aspirin, platelets, and cancer: The point of view of the internist. 108
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 108
The role of nitric oxide in the development of diabetic angiopathy. 107
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 107
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 107
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 107
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 106
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 106
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 106
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 106
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 106
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 106
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 105
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 105
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 104
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 104
Soluble forms of RAGE in internal medicine. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
Atherothrombotic disease and the metabolic syndrome. 102
Determinants of platelet activation in hypertensives with microalbuminuria. 102
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 102
Soluble RAGE in type 2 diabetes: association with oxidative stress. 101
COVID-19 and RAS: Unravelling an Unclear Relationship 101
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 100
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 100
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 99
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 99
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 99
Association between PAI-1 and Oxidative Stress in Android Obesity 98
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 98
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 98
Aspirin as antiplatelet agent in diabetes. PROS-. 98
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 97
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 97
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 96
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 96
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 96
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 95
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 95
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 95
Diabetes mellitus in the pre-school child. 94
The left atrial appendage: from embryology to prevention of thromboembolism 93
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 93
Insulin resistance as a determinant of platelet activation in obese women 92
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 92
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 92
Association between enhanced soluble CD40 ligand and platelet activation in hypertensives with microalbuminuria. 92
Totale 11.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.111
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021617 0 0 0 0 0 242 31 28 102 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.743 242 703 577 88 92 172 144 172 350 174 451 578
2025/20263.962 651 337 908 1.086 901 79 0 0 0 0 0 0
Totale 19.866